MXD3 regulation of DAOY cell proliferation dictated by time course of activation

BMC Cell Biology

Elva Dίaz¹  Kit S Lam²  Gustavo A Barisone¹  Tin Ngo² 

[1] Department of Pharmacology, UC Davis School of Medicine, 451 Health Sciences Drive, 3503 GBSF, Davis, CA 95616, USA;Department of Biochemistry and Molecular Medicine, University of California Davis School of Medicine, Davis, CA, USA

关键词: DAOY;    Medulloblastoma;    Proliferation;    MXD3;   

Others  :  1088726
DOI  :  10.1186/1471-2121-15-30

 received in 2013-12-03, accepted in 2014-07-02,  发布年份 2014

【 摘 要 】

Background

MXD3 is a basic-helix-loop-helix-leucine-zipper transcription factor involved in cellular proliferation. In previous studies we demonstrated that knock-down of MXD3 in the human medulloblastoma cell line DAOY resulted in decreased proliferation. Surprisingly, overexpression of MXD3 in DAOY cells also decreased proliferation and increased cell death, suggesting that persistent expression of MXD3 triggers an apoptotic response, perhaps as a fail-safe mechanism. To investigate this apparent paradox in detail we developed a tamoxifen inducible system to analyze the temporal effects of MXD3 in the proliferation and transcriptional response of DAOY cells upon acute induction compared with long-term expression of MXD3.

Results

We find that acute induction of MXD3 initially promotes cell cycle progression as assessed by a transient increase in bromodeoxyuridine incorporation. However, persistent induction of MXD3 ultimately results in decreased proliferation based on cell counts. Finally, with microarray expression profiling and gene ontology analysis we identify several major pathways enriched in response to acute (immune response, apoptosis, cell cycle) versus persistent (cell adhesion) MXD3 activation.

Conclusions

In this study, we demonstrate that acute MXD3 activation results in a transient increase in cell proliferation while persistent activation of MXD3 eventually results in an overall decrease in cell number, suggesting that the time course of MXD3 expression dictates the cellular outcome. Microarray expression profiling and gene ontology analysis indicate that MXD3 regulates distinct genes and pathways upon acute induction compared with persistent expression, suggesting that the cellular outcome is specified by changes in MXD3 transcriptional program in a time-dependent manner.

【 授权许可】

   
2014 Ngo et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

【 参考文献 】

• [1]Polkinghorn WR, Tarbell NJ: Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratification. Nat Clin Pract Oncol 2007, 4(5):295-304.
• [2]Wechsler-Reya R, Scott MP: The developmental biology of brain tumors. Annu Rev Neurosci 2001, 24:385-428.
• [3]Kool M, Korshunov A, Remke M, Jones DT, Schlanstein M, Northcott PA, Cho YJ, Koster J, Schouten-van Meeteren A, van Vuurden D, Clifford SC, Pietsch T, von Bueren AO, Rutkowski S, McCabe M, Collins VP, Bäcklund ML, Haberler C, Bourdeaut F, Delattre O, Doz F, Ellison DW, Gilbertson RJ, Pomeroy SL, Taylor MD, Lichter P, Pfister SM: Molecular subgroups of medulloblastoma: an international meta-analysis of transcriptome, genetic aberrations, and clinical data of WNT, SHH, Group 3, and Group 4 medulloblastomas. Acta Neuropathol 2012, 123(4):473-484.
• [4]Taylor MD, Northcott PA, Korshunov A, Remke M, Cho YJ, Clifford SC, Eberhart CG, Parsons DW, Rutkowski S, Gajjar A, Ellison DW, Lichter P, Gilbertson RJ, Pomeroy SL, Kool M, Pfister SM: Molecular subgroups of medulloblastoma: the current consensus. Acta Neuropathol 2012, 123(4):465-472.
• [5]Ingham PW, McMahon AP: Hedgehog signaling in animal development: paradigms and principles. Genes Dev 2001, 15(23):3059-3087.
• [6]Kenney AM, Cole MD, Rowitch DH: Nmyc upregulation by sonic hedgehog signaling promotes proliferation in developing cerebellar granule neuron precursors. Development 2003, 130(1):15-28.
• [7]Taylor MD, Liu L, Raffel C, Hui CC, Mainprize TG, Zhang X, Agatep R, Chiappa S, Gao L, Lowrance A, Hao A, Goldstein AM, Stavrou T, Scherer SW, Dura WT, Wainwright B, Squire JA, Rutka JT, Hogg D: Mutations in SUFU predispose to medulloblastoma. Nat Genet 2002, 31(3):306-310.
• [8]Li P, Du F, Yuelling LW, Lin T, Muradimova RE, Tricarico R, Wang J, Enikolopov G, Bellacosa A, Wechsler-Reya RJ, Yang ZJ: A population of Nestin-expressing progenitors in the cerebellum exhibits increased tumorigenicity. Nat Neurosci 2013, 16(12):1737-1744.
• [9]Yun JS, Rust JM, Ishimaru T, Diaz E: A novel role of the Mad family member Mad3 in cerebellar granule neuron precursor proliferation. Mol Cell Biol 2007, 27(23):8178-8189.
• [10]Barisone GA, Ngo T, Tran M, Cortes D, Shahi MH, Nguyen TV, Perez-Lanza D, Matayasuwan W, Diaz E: Role of MXD3 in Proliferation of DAOY Human Medulloblastoma Cells. PLoS One 2012, 7(7):e38508.
• [11]Jacobsen PF, Jenkyn DJ, Papadimitriou JM: Establishment of a human medulloblastoma cell line and its heterotransplantation into nude mice. J Neuropathol Exp Neurol 1985, 44(5):472-485.
• [12]Grandori C, Cowley SM, James LP, Eisenman RN: The Myc/Max/Mad network and the transcriptional control of cell behavior. Annu Rev Cell Dev Biol 2000, 16:653-699.
• [13]Ayer DE, Kretzner L, Eisenman RN: Mad: a heterodimeric partner for Max that antagonizes Myc transcriptional activity. Cell 1993, 72(2):211-222.
• [14]Hooker CW, Hurlin PJ: Of Myc and Mnt. J Cell Sci 2006, 119(Pt 2):208-216.
• [15]Kretzner L, Blackwood EM, Eisenman RN: Transcriptional activities of the Myc and Max proteins in mammalian cells. Curr Top Microbiol Immunol 1992, 182:435-443.
• [16]Ayer DE, Lawrence QA, Eisenman RN: Mad-Max transcriptional repression is mediated by ternary complex formation with mammalian homologs of yeast repressor Sin3. Cell 1995, 80(5):767-776.
• [17]Ayer DE, Laherty CD, Lawrence QA, Armstrong AP, Eisenman RN: Mad proteins contain a dominant transcription repression domain. Mol Cell Biol 1996, 16(10):5772-5781.
• [18]Hurlin PJ, Huang J: The MAX-interacting transcription factor network. Semin Cancer Biol 2006, 16(4):265-274.
• [19]Fox EJ, Wright SC: S-phase-specific expression of the Mad3 gene in proliferating and differentiating cells. Biochem J 2001, 359(Pt 2):361-367.
• [20]Hurlin PJ, Foley KP, Ayer DE, Eisenman RN, Hanahan D, Arbeit JM: Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis. Oncogene 1995, 11(12):2487-2501.
• [21]Gore Y, Lantner F, Hart G, Shachar I: Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression. Mol Biol Cell 2010, 21(11):1864-1871.
• [22]Grinberg AV, Hu CD, Kerppola TK: Visualization of Myc/Max/Mad family dimers and the competition for dimerization in living cells. Mol Cell Biol 2004, 24(10):4294-4308.
• [23]Fisher F, Crouch DH, Jayaraman PS, Clark W, Gillespie DA, Goding CR: Transcription activation by Myc and Max: flanking sequences target activation to a subset of CACGTG motifs in vivo. EMBO J 1993, 12(13):5075-5082.
• [24]Fox EJ, Wright SC: The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1. Biochem J 2003, 370(Pt 1):307-313.
• [25]Wilson AC: Setting the stage for S phase. Mol Cell 2007, 27(2):176-177.
• [26]Lee S, Schmitt CA, Reimann M: The Myc/macrophage tango: oncogene-induced senescence, Myc style. Semin Cancer Biol 2011, 21(6):377-384.
• [27]Evan GI, Wyllie AH, Gilbert CS, Littlewood TD, Land H, Brooks M, Waters CM, Penn LZ, Hancock DC: Induction of apoptosis in fibroblasts by c-myc protein. Cell 1992, 69(1):119-128.
• [28]Nair SK, Burley SK: X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors. Cell 2003, 112(2):193-205.
• [29]Nair SK, Burley SK: Structural aspects of interactions within the Myc/Max/Mad network. Curr Top Microbiol Immunol 2006, 302:123-143.
• [30]Crouch DH, Fisher F, Clark W, Jayaraman PS, Goding CR, Gillespie DA: Gene-regulatory properties of Myc helix-loop-helix/leucine zipper mutants: Max-dependent DNA binding and transcriptional activation in yeast correlates with transforming capacity. Oncogene 1993, 8(7):1849-1855.